Penumbra Inc (PEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures products for neuro and vascular markets. Its products are used for various procedures of thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuroarteriovenous malformation, body aneurysm and others. Its major products include neurovascular access systems, revascularization device, embolization coiling system and microcatheter among others. The company sells its products to specialist physicians, hospitals and clinics through direct sales organization in the US, Canada, Australia and most of the Europe. It also distributes its products through distributors worldwide. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.

Penumbra Inc Key Recent Developments

Apr 06,2020 Penumbra provides update on COVID-19 response and impact
Nov 25,2019 Maggie Yuen appointed Chief Financial Officer of Penumbra
Nov 07,2019 Penumbra reports third quarter 2019 financial results
Aug 29,2019 Sri Kosaraju promoted to President and CFO of Penumbra

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company